Publicacións (30) Publicacións de Eduardo Carracedo Martínez

2024

  1. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  2. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

2023

  1. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  2. Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

    European Neuropsychopharmacology, Vol. 71, pp. 96-108

2022

  1. Impact on In- and Out-of-Hospital Drug Prescriptions of Including a More Expensive Me-Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study

    Pharmacoepidemiology and Drug Safety, Vol. 31, Núm. 5, pp. 556-565

2020

  1. Impact of a change of bronchodilator medications in a hospital drug formulary on intra- A nd out-of-hospital drug prescriptions: Interrupted time series design with comparison group

    Implementation Science, Vol. 15, Núm. 1

  2. Impact of a health alert and its implementation on flutamide prescriptions for women: an interrupted time series analysis

    BMC health services research, Vol. 20, Núm. 1, pp. 597

2019

  1. Computerized Clinical Decision Support Systems and Antibiotic Prescribing: A Systematic Review and Meta-analysis

    Clinical Therapeutics, Vol. 41, Núm. 3, pp. 552-581

  2. Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group

    Implementation science : IS, Vol. 14, Núm. 1, pp. 75

2018

  1. Impact of Health Authority Control Measures Aimed at Reducing the Illicit Use of Anabolic-Androgenic Steroids

    European Addiction Research, Vol. 24, Núm. 1, pp. 28-36

2017

  1. The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors

    Farmacia Hospitalaria, Vol. 41, Núm. 1, pp. 49-67

  2. Trends in celecoxib and etoricoxib prescribing following removal of prior authorization requirement in Spain

    Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 2, pp. 185-188

2016

  1. Eficiencia del programa de seguimiento farmacoterapéutico de antipsicóticos parenterales de acción prolongada en el área sanitaria de Santiago de Compostela

    Gaceta Sanitaria, Vol. 30, Núm. 1, pp. 73-76

  2. Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study

    SAGE Open Medicine, Vol. 4

2015

  1. Control measures for anabolic androgenic steroid medicines

    Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 304-307

2012

  1. Impact of a health safety warning and prior authorisation on the use of piroxicam: A time-series study

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 3, pp. 281-284

2011

  1. Estudio sobre la utilización de la asociación clopidogrel con inhibidores de la bomba de protones en la práctica clínica habitual

    Atención Farmacéutica, Vol. 13, Núm. 3, pp. 181-183

  2. Estudio sobre la utilización de la asociación clopidogrel con inhibidores de la bomba de protones en la práctica clínica habitual

    Atencion Farmaceutica, Vol. 13, Núm. 3, pp. 181-183

  3. Influencia de una alerta sanitaria sobre la utilización de telitromicina

    Medicina Clinica

2010

  1. Case-crossover analysis of air pollution health effects: A systematic review of methodology and application

    Environmental Health Perspectives, Vol. 118, Núm. 8, pp. 1173-1182